Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05734313 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

Study acronym: UP-CBT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 2 of 2 entries
    • Site contacts updated at 1 of 2 sites
    • Eligibility criteria shortened, about 3 words
    v10
  2. Start date: Oct 31, 2023 to Mar 31, 2023
    • Site contacts updated at 1 of 2 sites
    v9
  3. Enrollment target: 150 to 94
    • Eligibility criteria revised
    • Study description expanded, about 76 words
    v8
  4. Start date changed from estimate of Nov 2023 to Oct 31, 2023v7
  5. Primary completion date: Jan 2027 to Dec 2027
    • Start date: Sep 30, 2023 to Nov 2023
    • Site details revised at 1 of 2 sites
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Jul 31, 2023 to Sep 30, 2023v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date: May 2023 to Jul 31, 2023
    • Site details revised at 2 of 2 sites
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Site contacts updated at 1 of 2 sitesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.
Trial Details
NCT Number NCT05734313
Lead Sponsor Albert Einstein College of Medicine
Collaborators: Juvenile Diabetes Research Foundation, DexCom, Inc.
Conditions
(from sponsor)		 Diabetes, Type 1 Diabetes
Related terms Anxiety Disorders, Depression, Diabetes Mellitus, Diabetes Mellitus, Type 1
Enrollment 94 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov